BBNX
Beta Bionics, Inc.
19.00$
-2.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +54.4% | +125.9% | -2.4% | +0.0% | -0.4% | -7.4% | -4.0% | |
| – | – | – | – | – | +61.0% | +97.0% | +9.2% | -5.6% | -0.8% | -7.4% | -6.8% | |
| – | – | +264.2% | – | – | +74.1% | +39.5% | -17.4% | +9.7% | -18.0% | -4.3% | +46.7% | |
| – | – | +0.0% | – | – | +70.1% | +123.5% | +7.9% | -8.4% | -4.2% | -8.9% | -9.5% | |
| – | – | – | – | – | +60.7% | -8.2% | +22.0% | +6.1% | +39.6% | -10.1% | +11.6% | |
| – | – | – | – | – | +18.0% | +18.1% | +10.1% | +17.6% | +6.6% | +9.2% | +0.8% | |
| – | – | -214.0% | – | – | +14.9% | -67.0% | +16.8% | +24.5% | +16.6% | -19.4% | +8.6% | |
| – | – | – | – | – | +18.3% | -22.0% | +18.2% | +30.3% | +21.8% | -25.0% | +12.2% | |
| – | – | – | – | – | +5.4% | -0.3% | -0.3% | +30.3% | -2.1% | -5.1% | -13.5% | |
| – | – | – | – | – | +0.1% | +21.1% | -0.9% | +30.3% | +12.0% | -53.6% | +130.8% | |
| – | – | +0.0% | – | – | +131.3% | +312.8% | -3.9% | -2.3% | -2.4% | -5.7% | -5.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +1.1% | -1.1% | +0.0% | +0.0% | +0.6% | +0.6% | +0.6% | -7.1% | +9.6% | +0.2% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.